CFR (%, 95%CI) | |||
---|---|---|---|
Clinical presentation | Lower transmission area | Higher transmission area | Overall |
Coma | 2/13 (15.3%, 1.9–45.4%) | 9/53 (16.9%, 8.1–29.8%)) | 11/66 (16.7%, 8.6–27.9%)) |
Convulsions | 7/102 (6.9%, 2.8–13.6%)) | 7/86 (8.1%, 3.3–16.0%) | 14/188 (7.4%, 4.1–12.2%) |
Prostration | 10/154 (6.5%, 3.1–11.6%) | 18/213 (5.1–13.0%) | 28/367 (7.6%, 5.1–10.8%) |
Respiratory Distress | 5/21 (23.8%, 8.2–47.2%) | 8/29 (27.6%, 12.8–47.2%) | 13/50 (26.0%, 14.6–40.3%) |
Abnormal bleeding | – | – | – |
Circulatory collapse/shock | 0/2 (–) | 2/9 (22.2%, 2.8–60.0%) | 2/11 (18.2%, 2.3–51.8%) |
Haemoglobinuria | 1/23 (4.3%, 0.1–21.9%)) | 3/53 (5.7%, 1.2–15.7%) | 4/76 (5.3%, 1.4–12.9%) |
Incoercible vomiting | 3/56 (5.4%, 1.1–14.9%) | 1/42 (2.4%, 0.1–12.6%) | 4/98 (4.1%, 1.1–10.1%) |
Lethargy | 5/144 (3.5%, 1.1–7.9%) | 3/34 (8.8%, 1.8–23.7%) | 8/178 (4.5%, 1.9–8.7%) |
Inability to drink /suck | 5/18 (27.8%, 9.7–53.5%) | 2/18 (11.1%, 1.4–34.7%) | 7/36 (19.4%, 8.2–36.0%) |
Severe anaemia | 7/243 (2.9%, 1.2–5.8%) | 8/180 (4.4%, 1.9–8.6%) | 15/423 (3.5%, 2.0–5.8%) |
Hypoglycaemia | 3/17 (17.6%, 3.8–43.4%) | 7/23 (30.4%, 13.2–52.9%) | 10/40 (25%, 12.7–41.2%) |